HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 288/5/G1084    most recent 00004.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Kitano, M. Articles by Hasegawa, J. Search for Related Content PubMed PubMed Citation Articles by Kitano, M. Articles by Hasegawa, J.

MUCOSAL BIOLOGY

Ischemia of rat stomach mobilizes ECL cell histamine

¹Department of Clinical Pharmacology, Faculty of Medicine, Tottori University, Tottori, Japan; ²Department of Pharmacology, Institute of Physiological Sciences, University of Lund, Lund, Sweden; and ³Department of Gastroenterology and Hepatology, Kinki University, School of Medicine, Osaka, Japan

Submitted 8 January 2004 ; accepted in final form 17 November 2004

Microdialysis was used to study how ischemia-evoked gastric mucosal injury affects rat stomach histamine, which resides in enterochromaffin-like (ECL) cells and mast cells. A microdialysis probe was inserted into the gastric submucosa, and the celiac artery was clamped (30 min), followed by removal of the clamp. Microdialysate histamine was determined by enzyme-linked immunosorbent assay. In addition, we studied the long-term effects of ischemia on the oxyntic mucosal histidine decarboxylase activity in omeprazole-treated rats. Gastric mucosal lesions induced by the ischemia were enlarged on removal of the clamp. The microdialysate histamine concentration increased immediately on clamping (50-fold rise within 30 min) and declined promptly after the clamp was removed. In contrast, histidine decarboxylase activity of the ECL cells was lowered by the ischemia and returned to preischemic values 9 days later. Mast cell-deficient rats responded to ischemia-reperfusion much like wild-type rats with respect to histamine mobilization. Pretreatment with the irreversible inhibitor of histidine decarboxylase, -fluoromethylhistidine, which is known to eliminate histamine from ECL cells, prevented the rise in microdialysate histamine. Pharmacological blockade of acid secretion (cimetidine or omeprazole) prevented the lesions induced by ischemia-reperfusion insult but not the mobilization of histamine. In conclusion, ischemia of the celiac artery mobilizes large amounts of histamine from ECL cells, which occurs independently of the gross mucosal lesions. The prompt reduction of the mucosal histidine decarboxylase activity in response to ischemia probably reflects ECL cell damage. The lesions develop not because of mobilization of histamine per se but because of ischemia plus reperfusion plus gastric acid.

enterochromaffin-like cell; ischemia-reperfusion; histidine decarboxylase

This article has been cited by other articles:

				N. W. G. Lambrecht, I. Yakubov, and G. Sachs Fasting-induced changes in ECL cell gene expression Physiol Genomics, October 19, 2007; 31(2): 183 - 192. [Abstract] [Full Text] [PDF]